Literature DB >> 36030429

The influence of prior dental pathology on medical complications and peri-prosthetic joint infections following primary shoulder arthroplasty.

Adam M Gordon1, Andrew R Horn2, Keith B Diamond2, Eric S Roth2, Miriam D Weisberg2, Ramin Sadeghpour2, Jack Choueka2.   

Abstract

PURPOSE: Antibiotic prophylaxis before invasive dental procedures is a common practice in the USA. Consensus regarding the influence of prior dental pathology (DP) on postoperative complications is lacking. The objectives are to determine the association of DP prior to shoulder arthroplasty (SA) on: (1) lengths of stay (LOS), (2) medical complications, (3) readmissions, (4) implant-related complications including peri-prosthetic joint infections (PJIs) and (5) healthcare expenditures.
METHODS: The PearlDiver database was queried for primary shoulder arthroplasty from 2010 to 2020. Patients with history of dental caries or dental implant placement before SA represented the study group (n = 1419). Patients without prior DP represented controls (n = 7062). Study group patients were 1:5 ratio matched to controls by age, sex, and comorbidities. Outcomes included LOS, 90-day complications, readmissions, 2-year implant-related complications, and healthcare reimbursements. Logistic regression was used to calculate odds ratios (OR) of complications and readmissions. T tests compared LOS and costs. P values < 0.003 were significant.
RESULTS: LOS (2.17 vs. 2.07 days; p = 0.071) were similar between groups. Patients with DP had higher 90-day medical complications compared to controls (OR: 1.74, p < 0.0001), including myocardial infarctions (2.2% vs. 0.8%; OR: 2.79, p < 0.0001), acute kidney injuries (8.3% vs. 4.6%; OR: 1.92, p < 0.0001), and pneumonias (8.7% vs. 5.3%; OR: 1.72, p < 0.0001). Readmission rates (1.97% vs. 1.54%; p = 0.248) were similar. Two-year implant complications were higher in patients with DP compared to controls (16.1% vs. 11.5%; OR: 1.38, p = 0.0003), including dislocations (6.4% vs. 4.5%; OR: 1.45, p = 0.002) and mechanical loosenings (4.0% vs. 2.4%; OR: 1.67, p = 0.001); however, PJIs were similar (2.2% vs. 1.9%; OR: 1.12, p = 0.583). Healthcare expenditures between groups were similar ($12,611 vs. $12,059; p = 0.075).
CONCLUSION: Patients with prior DP have higher 90-day medical complications and 2-year implant-related complications. Two-year incidence of PJIs were similar between groups. These findings can help shoulder surgeons counsel patients with a pertinent dental history. LEVEL OF EVIDENCE III: Retrospective comparative study.
© 2022. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.

Entities:  

Keywords:  Complications; Database; Dental work; Infection; Oral hygiene; Outcomes; Peri-prosthetic joint infections; Shoulder arthroplasty

Year:  2022        PMID: 36030429     DOI: 10.1007/s00590-022-03378-w

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  33 in total

1.  The American Academy of Orthopaedic Surgeons and the American Dental Association clinical practice guideline on the prevention of orthopaedic implant infection in patients undergoing dental procedures.

Authors:  Michael P Rethman; William Watters; Elliot Abt; Paul A Anderson; Karen C Carroll; Richard Parker Evans; Harry C Futrell; Kevin Garvin; Stephen O Glenn; Michael J Goldberg; John Hellstein; Angela Hewlett; David Kolessar; Calin Moucha; Richard J O' Donnell; Douglas R Osmon; John O' Toole; Anthony Rinella; Mark J Steinberg; William Robert Martin; Deborah S Cummins; Sharon Song; Patrick Sluka; Kevin Boyer; Anne Woznica; Helen Ristic; Nicholas Buck Hanson
Journal:  J Bone Joint Surg Am       Date:  2013-04-17       Impact factor: 5.284

2.  Diagnosis and Management of Periprosthetic Joint Infection After Shoulder Arthroplasty.

Authors:  Maxwell E Cooper; Nikunj N Trivedi; Lakshmanan Sivasundaram; Michael R Karns; James E Voos; Robert J Gillespie
Journal:  JBJS Rev       Date:  2019-07

Review 3.  Periprosthetic Infections of the Shoulder.

Authors:  Siddartha Simha; Edward J W Shields; J Michael Wiater
Journal:  JBJS Rev       Date:  2018-09

4.  Hematogenous infection in total joint replacement. Recommendations for prophylactic antibiotics.

Authors:  G L Lattimer; P A Keblish; T B Dickson; C G Vernick; W J Finnegan
Journal:  JAMA       Date:  1979-11-16       Impact factor: 56.272

5.  Patient and procedure-specific risk factors for deep infection after primary shoulder arthroplasty.

Authors:  Jason Richards; Maria C S Inacio; Michael Beckett; Ronald A Navarro; Anshuman Singh; Mark T Dillon; Jeff F Sodl; Edward H Yian
Journal:  Clin Orthop Relat Res       Date:  2014-06-07       Impact factor: 4.176

6.  Treatment strategies for infection after reverse shoulder arthroplasty.

Authors:  Reinhold Ortmaier; Herbert Resch; Wolfgang Hitzl; Michael Mayer; Ottokar Stundner; Mark Tauber
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-06-08

Review 7.  Periprosthetic Infections of the Shoulder: Diagnosis and Management.

Authors:  E Scott Paxton; Andrew Green; Van S Krueger
Journal:  J Am Acad Orthop Surg       Date:  2019-11-01       Impact factor: 3.020

Review 8.  Perioperative and Modifiable Risk Factors for Periprosthetic Joint Infections (PJI) and Recommended Guidelines.

Authors:  Vignesh K Alamanda; Bryan D Springer
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

Review 9.  Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Taulant Muka; Clare Oliver-Williams; Veronica Colpani; Setor Kunutsor; Susmita Chowdhury; Rajiv Chowdhury; Maryam Kavousi; Oscar H Franco
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

10.  Prevalence of Shoulder Arthroplasty in the United States and the Increasing Burden of Revision Shoulder Arthroplasty.

Authors:  Kevin X Farley; Jacob M Wilson; Anjali Kumar; Michael B Gottschalk; Charles Daly; Joaquin Sanchez-Sotelo; Eric R Wagner
Journal:  JB JS Open Access       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.